{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:22Z","timestamp":1787238022766,"version":"build-2736575974"},"publisher-location":"Chichester, UK","reference-count":161,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002252","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:33:39Z","timestamp":1069367619000},"source":"Crossref","is-referenced-by-count":44,"title":["Antihypertensive drug therapy for mild to moderate hypertension during pregnancy"],"prefix":"10.1002","author":[{"given":"E","family":"Abalos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Duley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DW","family":"Steyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DJ","family":"Henderson-Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,4,23]]},"reference":[{"key":"10.1002\/14651858.CD002252-BIB1|cit1","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1097\/00005344-198700103-00025","article-title":"Ketanserin versus alpha methyldopa in the treatment of hypertension during pregnancy: a preliminary report","volume":"10 (suppl 3)","author":"Voto","year":"1987","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD002252-BIB2|cit2","unstructured":"Casavilla F Vega HR Prospective and randomized study on mepindolol and alpha-methydopa efficacy in arterial hypertension (AH) treatment during pregnancy. World Congress of Gynecology and Obstetrics; 1988; October 23-28; Brazil, 1988:182"},{"key":"10.1002\/14651858.CD002252-BIB3|cit3","first-page":"341","article-title":"Propranolol in pregnancy - three-year prospective study","volume":"2","author":"Livingstone","year":"1983","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002252-BIB6|cit4","doi-asserted-by":"crossref","unstructured":"Gallery EDM Hunyor SN Saunders DM Gyory AZ A randomized trial of oxyprenolol and a-methyl dopa in therapy of hypertension in pregnancy. 1st Congress of the International Society of Hypertension in Pregnancy; 1978 September 27-29; Dublin, Ireland, 1978:88","DOI":"10.5694\/j.1326-5377.1978.tb141950.x"},{"key":"10.1002\/14651858.CD002252-BIB4|cit5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bmj.291.6495.563","article-title":"Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa","volume":"291","author":"Gallery","year":"1985","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB5|cit6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.1.6178.1591","article-title":"Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy","volume":"1","author":"Gallery","year":"1979","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB7|cit7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-0528.1990.tb01738.x","article-title":"A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension","volume":"97","author":"Plouin","year":"1990","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB9|cit8","first-page":"952","article-title":"Antihypertensive efficacy and perinatal safety of labetalol in the treatment of hypertension in pregnancy: a randomised comparison to methyldopa","volume":"80","author":"Plouin","year":"1987","journal-title":"Archives des Maladies du Coeur"},{"key":"10.1002\/14651858.CD002252-BIB8|cit9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1471-0528.1988.tb06571.x","article-title":"Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial","volume":"95","author":"Plouin","year":"1988","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB11|cit10","unstructured":"Blazquez Lardoux H Leperlier E Randomized and comparative study of methyl dopa (MD), acebutolol (ACE) and labetalol for the treatment of moderate hypertension during pregnancy (HDP). 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:100"},{"key":"10.1002\/14651858.CD002252-BIB10|cit11","first-page":"137","article-title":"Randomized and comparative study of methyldopa (MD), acebutolol (ACE) and labetalol for the treatment of moderate hypertension during pregnancy (HDP)","volume":"91","author":"Lardoux","year":"1988","journal-title":"Archives des Maladies du Coeur"},{"key":"10.1002\/14651858.CD002252-BIB12|cit12","first-page":"354","article-title":"Nicardipine vs metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial","volume":"84","author":"Jannet","year":"1994","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB13|cit13","first-page":"225","article-title":"Nicardipine vs metoprolol in the treatment of hypertension during pregnancy: A randomized comparative trial","volume":"49","author":"Jannet","year":"1995","journal-title":"International Journal of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD002252-BIB14|cit14","unstructured":"Li CY Lao TT Yu KM Wong SP Leung CF The effect of labetalol on mild pre-eclampsia. Proceedings of 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy, 1990:191"},{"key":"10.1002\/14651858.CD002252-BIB15|cit15","first-page":"39","article-title":"A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension","volume":"44","author":"Oumachigui","year":"1992","journal-title":"Indian Heart Journal"},{"key":"10.1002\/14651858.CD002252-BIB16|cit16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1471-0528.1991.tb13387.x","article-title":"The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment","volume":"98","author":"Blake","year":"1991","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB17|cit17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0020-7292(86)90015-9","article-title":"Management of pregnancy-induced hypertension with pindolol - comparative study with methyldopa","volume":"24","author":"Ellenbogen","year":"1986","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD002252-BIB18|cit18","unstructured":"Jaschevatzky OE Davidson A Ellenbogen A Anderman S Grunstein S Comparative study of pindolol and methyldopa and transplacental cross of pindolol in PIH. 5th International Congress for the International Society for the study of Hypertension in Pregnancy; 1986 7-10 July; Nottingham, England, 1986:137"},{"key":"10.1002\/14651858.CD002252-BIB19|cit19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0028-2243(86)90066-3","article-title":"Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol","volume":"22","author":"Rosenfeld","year":"1986","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD002252-BIB21|cit20","unstructured":"Bar J Hirsch M Friedman S Fuchs J Ovadia J Bott-Kanner G The effect of beta-adrenergic blocker pindolol on platelet function in chronic hypertensive pregnancies. Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994; Sydney, Australia, 1994:155"},{"key":"10.1002\/14651858.CD002252-BIB20|cit21","first-page":"207","article-title":"Antihypertensive therapy in the management of hypertension in pregnancy - a clinical double-blind study of pindolol","volume":"B11","author":"Bott-Kanner","year":"1992","journal-title":"Clinical and Experinental Hypertension"},{"key":"10.1002\/14651858.CD002252-BIB22|cit22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/10641959609015702","article-title":"Effect of the beta-adrenergic blocker pindolol on platelet function in chronic hypertensive pregnancy","volume":"15","author":"Hirsch","year":"1996","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD002252-BIB24|cit23","unstructured":"Paran E Baile Y Holzberg G Masor M Zmora E Insler V Treatment of hypertension in pregnancy: different regime, different outcome. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:105"},{"key":"10.1002\/14651858.CD002252-BIB23|cit24","first-page":"119","article-title":"Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension","volume":"33","author":"Paran","year":"1995","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002252-BIB25|cit25","unstructured":"Paran E Maisner I Holzberg G Mazor M Zmora E Biale Y Beta-blocker treatment of PIH correlated with uteroplacental blood flow measurement. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:109"},{"key":"10.1002\/14651858.CD002252-BIB26|cit26","first-page":"373","article-title":"Evaluation of nifedipine monotheraphy in the management of pregnancy hypertension","volume":"6","author":"Catalano","year":"1997","journal-title":"Giornale Italiano Di Ostetricia e Ginecologia"},{"key":"10.1002\/14651858.CD002252-BIB28|cit27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1471-0528.2000.tb13342.x","article-title":"Nifedipine administered in pregnancy: effect on the development of children at 18 months","volume":"107","author":"Bortolus","year":"2000","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB27|cit28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1471-0528.1998.tb10201.x","article-title":"Nifedipine versus expectant management in mild to moderate hypertension in pregnancy","volume":"105","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB29|cit29","first-page":"51","article-title":"Multicentric, randomized, clinical trial on the efficacy of long-acting nifedipine in improving the prognosis of pregnancy in women with mild or moderate chronic or pregnancy-induced hypertension","volume":"6","author":"Luchini","year":"1991","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD002252-BIB30|cit30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/10641959909009615","article-title":"24-hour ambulatory blood pressure monitoring: a comparison between transdermal glyceryl-trinitrate and oral nifedipine","volume":"18","author":"Neri","year":"1999","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD002252-BIB31|cit31","unstructured":"Odendaal HJ Schabort I Pattinson RC Prazosin for the treatment of hypertension in pregnancy: a randomized control trial Oxford Database of Perinatal Trials 1991 Chalmers I (editor). Oxford: Oxford University Press, 1991"},{"key":"10.1002\/14651858.CD002252-BIB32|cit32","unstructured":"Eloff WJ The use of nifedipine vs methyldopa in mild to moderate pregnancy associated hypertension. Proceedings of the 12th Conference on Priorities in Perinatal Care; 1993; South Africa, 1993:130-3"},{"key":"10.1002\/14651858.CD002252-BIB35|cit33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00016348409157131","article-title":"Neonatal effects of beta-blocking drugs in pregnancy","volume":"118","author":"Finnstrom","year":"1984","journal-title":"Acta Obstetricia et Gynecologica Scandinavica Supplement"},{"key":"10.1002\/14651858.CD002252-BIB38|cit34","unstructured":"Ryden G Karlberg BE Wichman K Metoprolol in the treatment of hypertension in pregnancy - effect on the mother and foetus. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 Jun 18-21; Amsterdam, The Netherlands, 1984:38"},{"key":"10.1002\/14651858.CD002252-BIB34|cit35","first-page":"195","article-title":"Metoprolol in the treatment of mild to moderate hypertension in pregnancy - effects on fetal heart activity","volume":"5","author":"Wichman","year":"1986","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002252-BIB37|cit36","unstructured":"Wichman K Ezitis J Finnstrom O Ryden G Metoprolol in the treatment of hypertension in pregnancy - effects on the newborn baby. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands, 1984:40"},{"key":"10.1002\/14651858.CD002252-BIB33|cit37","first-page":"141","article-title":"Metoprolol in the treatment of mild to moderate hypertension in pregnancy - effects on the mother","volume":"B4","author":"Wichman","year":"1985","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002252-BIB36|cit38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/00365518409085385","article-title":"A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy","volume":"106","author":"Wichman","year":"1984","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1002\/14651858.CD002252-BIB39|cit39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/00016348509156729","article-title":"A prospective controlled trial of metoprolol-hydralazine treatment in hypertension during pregnancy","volume":"64","author":"Hogstedt","year":"1985","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD002252-BIB41|cit40","unstructured":"Hjertberg R Faxelius G Lagercrantz H Neonatal adaptation in hypertensive pregnancy - a study of labetalol vs hydralazine treatment. Proceedings of 14th European Congress of Perinatal Medicine; 1994; Helsinki, Finland, 1994:18"},{"key":"10.1002\/14651858.CD002252-BIB40|cit41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/jpme.1993.21.1.69","article-title":"Neonatal adaption in hypertensive pregnancy - a study of labetalol vs hydralazine treatment","volume":"21","author":"Hjertberg","year":"1993","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1002\/14651858.CD002252-BIB43|cit42","first-page":"3","article-title":"Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: A randomized placebo-controlled study","volume":"46","author":"Wide-Swensson","year":"1994","journal-title":"International Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB42|cit43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0002-9378(95)90357-7","article-title":"Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: A randomized placebo-controlled study","volume":"173","author":"Wide-Swensson","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB44|cit44","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0140-6736(68)90650-8","article-title":"A controlled trial of hypotensive agents in hypertension in pregnancy","volume":"2","author":"Leather","year":"1968","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002252-BIB48|cit45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(82)92202-4","article-title":"Final report on study of hypertension during pregnancy: the effects of specific treatment on the growth and development of the children","volume":"1","author":"Cockburn","year":"1982","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002252-BIB46|cit46","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1471-0528.1978.tb15856.x","article-title":"Neonatal head circumference and the treatment of maternal hypertension","volume":"85","author":"Moar","year":"1978","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB47|cit47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-3782(77)90029-9","article-title":"Hypertension during pregnancy, with and without specific hypotensive treatment. I. Perinatal factors and neonatal morbidity","volume":"1","author":"Mutch","year":"1977","journal-title":"Early Human Development"},{"key":"10.1002\/14651858.CD002252-BIB52|cit48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0378-3782(77)90030-5","article-title":"Hypertension during pregnancy, with and without specific hypotensive treatment. II The growth and development of the infant in the first year of life","volume":"1","author":"Mutch","year":"1977","journal-title":"Early Human Development"},{"key":"10.1002\/14651858.CD002252-BIB51|cit49","first-page":"341","article-title":"The children of women who had hypertension during pregnancy","volume-title":"Hypertension in pregnancy","author":"Ounsted","year":"1988"},{"key":"10.1002\/14651858.CD002252-BIB50|cit50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1471-0528.1980.tb04420.x","article-title":"Hypertension during pregnancy with and without specific treatment: the development of the children at the age of four years","volume":"87","author":"Ounsted","year":"1980","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB49|cit51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1471-0528.1977.tb12616.x","article-title":"Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects","volume":"84","author":"Redman","year":"1977","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB45|cit52","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(76)90597-3","article-title":"Fetal outcome in trial of antihypertensive treatment in pregnancy","volume":"2","author":"Redman","year":"1976","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002252-BIB54|cit53","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/10641968009037147","article-title":"Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension","volume":"2","author":"Lamming","year":"1980","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002252-BIB55|cit54","doi-asserted-by":"crossref","unstructured":"Lamming GD Symonds EM Comparison of the alpha and beta blocking drug labetalol and aldomet in the treatment of pregnancy induced hypertension. Proceedings of the 2nd Congress of the International Society for the Study of Hypertension in Pregnancy; 1980 December 1-4; Cairo, Egypt, 1980:9","DOI":"10.3109\/10641968009037147"},{"key":"10.1002\/14651858.CD002252-BIB53|cit55","doi-asserted-by":"crossref","first-page":"217S","DOI":"10.1111\/j.1365-2125.1979.tb04784.x","article-title":"Use of labetalol and methyldopa in pregnancy-induced hypertension","volume":"8","author":"Lamming","year":"1979","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"Supp 1","key":"10.1002\/14651858.CD002252-BIB57|cit56","first-page":"295","article-title":"A randomised trial of the antihypertensive agent, labetalol, against bed rest in pregnancy hypertension","volume":"237","author":"Cameron","year":"1985","journal-title":"Archives of Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB60|cit57","first-page":"156","article-title":"Increased blood viscosity in pre-eclampsia: Effect of treatment with labetalol","volume":"50","author":"Lang","year":"1983","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD002252-BIB59|cit58","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1471-0528.1984.tb04780.x","article-title":"Blood rheology in pre-eclampsia and intrauterine growth retardation: effects of blood pressure reduction with labetalol","volume":"91","author":"Lang","year":"1984","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB58|cit59","first-page":"141","volume-title":"Intrauterine growth retardation and maternal labetalol treatment in a random allocation controlled study [MD thesis]","author":"Walker","year":"1992"},{"key":"10.1002\/14651858.CD002252-BIB56|cit60","unstructured":"Walker JJ Crooks A Erwin L Calder AA Labetalol in pregnancy-induced hypertension: fetal and maternal effects. International Congress Series 591. Reilly A, Symonds EM editor(s). Excerpta Medica 1982 148 60"},{"key":"10.1002\/14651858.CD002252-BIB65|cit61","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/adc.59.11.1061","article-title":"First year of life after the use of atenolol in pregnancy associated hypertension","volume":"59","author":"Reynolds","year":"1984","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD002252-BIB61|cit62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9378(84)80145-3","article-title":"Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol","volume":"150","author":"Rubin","year":"1984","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB63|cit63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2165\/00003495-198300252-00061","article-title":"Atenolol in the management of hypertension during pregnancy","volume":"25","author":"Rubin","year":"1983","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD002252-BIB64|cit64","first-page":"431","article-title":"Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension","volume":"1","author":"Rubin","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002252-BIB62|cit65","unstructured":"Rubin PC Butters L Reynolds B Low RAL Atenolol in the management of pregnancy associated hypertension: obstetric and paediatric aspects. 4th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands, 1984:41"},{"key":"10.1002\/14651858.CD002252-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/bmj.286.6382.1927","article-title":"Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy","volume":"286","author":"Fidler","year":"1983","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB67|cit67","first-page":"202","article-title":"Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy","volume":"286","author":"Fidler","year":"1983","journal-title":"Obstetrical and Gynecological Survey"},{"key":"10.1002\/14651858.CD002252-BIB70|cit68","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/bmj.285.6348.1116-b","article-title":"Atenolol: side effects in the newborn infant","volume":"285","author":"Thorley","year":"1982","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB68|cit69","first-page":"168","article-title":"Randomised trial of atenolol and methyl dopa in pregnancy related hypertension","volume":"133","author":"Thorley","year":"1984","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002252-BIB69|cit70","unstructured":"Thorley KJ Randomised trial of atenolol and methyl dopa in pregnancy related hypertension. 4th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands, 1984:53"},{"key":"10.1002\/14651858.CD002252-BIB72|cit71","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1471-0528.1992.tb13698.x","article-title":"A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension","volume":"99","author":"Pickles","year":"1992","journal-title":"Britisth Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB71|cit72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1471-0528.1989.tb01574.x","article-title":"The fetal outcome in a randomized double-blind controlled trial of labetalol vs placebo in pregnancy-induced hypertension","volume":"96","author":"Pickles","year":"1989","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB73|cit73","unstructured":"Pickles CJ Symonds EM Broughton Pipkin F The fetal outcome of early intervention therapy in pregnancy induced hypertension. A randomised, double-blind controlled trial of labetalol vs placebo. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:107"},{"key":"10.1002\/14651858.CD002252-BIB74|cit74","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bmj.301.6752.587","article-title":"Atenolol in essential hypertension during pregnancy","volume":"301","author":"Butters","year":"1990","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB75|cit75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/01443619209004032","article-title":"Intra-uterine growth retardation and maternal labetalol treatment in a random allocation controlled study","volume":"12","author":"Cruickshank","year":"1992","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB78|cit76","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/bmj.301.6760.1103-b","article-title":"Atenolol in essential hypertension during pregnancy","volume":"301","author":"Cruickshank","year":"1990","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB76|cit77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0028-2243(92)90192-2","article-title":"Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study","volume":"45","author":"Cruickshank","year":"1992","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD002252-BIB77|cit78","first-page":"333","article-title":"Maternal obstetric outcome measures in a randomised controlled study of labetalol in the treatment of hypertension in pregnancy","volume":"B10","author":"Cruickshank","year":"1991","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD002252-BIB79|cit79","first-page":"489","article-title":"Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension","volume":"53","author":"Arias","year":"1979","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB80|cit80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0020-7292(87)90181-0","article-title":"Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study","volume":"25","author":"Weitz","year":"1987","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD002252-BIB81|cit81","first-page":"323","article-title":"A comparison of labetalol plus hospitalization vs hospitalization alone in the management of preeclampsia remote from term","volume":"70","author":"Sibai","year":"1987","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB82|cit82","unstructured":"Sibai BM The need of hypertensive drugs in management of mild to moderate pregnant hypertension. Proceedings of 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy, 1990:133"},{"key":"10.1002\/14651858.CD002252-BIB83|cit83","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0002-9378(90)91297-P","article-title":"A comparison of no medication vs methyldopa or labetalol in chronic hypertension during pregnancy","volume":"162","author":"Sibai","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB86|cit84","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1055\/s-2008-1040763","article-title":"The effect of nifedipine on urinary excretion of calcium in preeclampsia","volume":"14","author":"Barton","year":"1997","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD002252-BIB84|cit85","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9378(12)80005-6","article-title":"A randomized prospective comparison of nifedipine and bed rest vs bed rest alone in the management of preeclampsia remote from term","volume":"167","author":"Sibai","year":"1992","journal-title":"Amercian Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB85|cit86","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0002-9378(12)91181-3","article-title":"A randomized prospective comparison of nifedipine and bed rest vs bed rest alone in the management of preeclampsia remote from term","volume":"166","author":"Sibai","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB87|cit87","first-page":"139","article-title":"Evaluation of antihypertensives in pregnancy: Prospective randomized study of mepindolol and alpha methyldopa","author":"Faneite","year":"1988","journal-title":"Revista de Obstetricia y Ginecologia de Venezuela"},{"key":"10.1002\/14651858.CD002252-BIB88|cit88","first-page":"95","article-title":"The use of atenolol to prevent preeclampsia and superimposed preeclampsia","volume":"46","author":"Fabregues","year":"1994","journal-title":"International Journal of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD002252-BIB91|cit89","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1440-1681.1984.tb00277.x","article-title":"Effect of antihypertensive drugs on neonatal blood pressure","volume":"11","author":"Henderson-Smart","year":"1984","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1002\/14651858.CD002252-BIB90|cit90","unstructured":"Horvath JS Phippard A Korda A Henderson-Smart D Child A Duggin GG A controlled trial comparing clonidine hydrochloride and alpha methyl dopa in pregnant women with hypertension. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands, 1984:246"},{"key":"10.1002\/14651858.CD002252-BIB89|cit91","first-page":"634","article-title":"Clonidine hydrochloride - a safe and effective antihypertensive agent in pregnancy","volume":"66","author":"Horvath","year":"1985","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB93|cit92","unstructured":"Phippard A Fisher W Child A Henderson-Smart D Horvarth J Korda A A randomized, placebo-controlled study on the effect of therapy for mild to moderate hypertension in primigravidae. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:112"},{"key":"10.1002\/14651858.CD002252-BIB92|cit93","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5694\/j.1326-5377.1991.tb121126.x","article-title":"Early blood pressure control improves pregnancy outcome in primigravid women with mild hypertension","volume":"154","author":"Phippard","year":"1991","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD002252-BIB94|cit94","unstructured":"Loquet Ph Buytaert Ph Renier M The influence of pindolol and atenolol on serial feto-placental blood flow measurements in non-proteinuric hypertension in pregnancy. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:111"},{"key":"10.1002\/14651858.CD002252-BIB95|cit95","unstructured":"Renier M Loquet P Buytaert P The influence of pindolol and atenolol on serial feto-placental blood flow measurements in non-proteinuric hypertension in pregnancy. Proceedings of 11th European Congress of Perinatal Medicine;1988; Rome, Italy, 1988"},{"issue":"9","key":"10.1002\/14651858.CD002252-BIB96|cit96","first-page":"533","article-title":"[Treatment of hypertension syndrome of pregnancy with ligustrazine]","volume":"11","author":"Qian","year":"1991","journal-title":"Chung Hsi I Chieh Ho Tsa Chih"},{"issue":"6","key":"10.1002\/14651858.CD002252-BIB97|cit97","first-page":"541","article-title":"Atenolol and bisoprolol in the treatment of mild and moderately severe hypertension","volume":"39","author":"Soucek","year":"1993","journal-title":"Vnitrni Lekarstvi"},{"key":"10.1002\/14651858.CD002252-BIB98|cit98","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0020-7292(93)90770-W","article-title":"Evaluation of calcium-antagonist (Nifedipine) in the treatment of pre-eclampsia","volume":"40","author":"Ismail","year":"1993","journal-title":"International Journal of Gynecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD002252-BIB99|cit99","first-page":"579","article-title":"Randomised comparison of atenolol and pindolol for treatment of hypertension in pregnancy","volume":"44","author":"Tuimala","year":"1988","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD002252-BIB100|cit100","unstructured":"Tuimala R Hartikainen-Sorri AL Treatment of hypertension during pregnancy by beta blocking agents. 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands, 1984:52"},{"key":"10.1002\/14651858.CD002252-BIB101|cit101","unstructured":"Yla-Outinen A Tuimala R Management of pregnancy induced hypertension by using nifedipine - a prospective randomized trial. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:133"},{"key":"10.1002\/14651858.CD002252-BIB102|cit102","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0301-2115(95)02197-F","article-title":"Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study","volume":"62","author":"R\u00e4s\u00e4nen","year":"1995","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD002252-BIB103|cit103","unstructured":"Madonna O M'Pio I Labeeuw M Pozet N Zech P Evaluation of renal function in pregnant hypertensives under treatment. A comparison between methyldopa, pindolol and atenolol. 6th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:260"},{"key":"10.1002\/14651858.CD002252-BIB104|cit104","unstructured":"Ciraru-Vigneron N Pruna A Mintz P Bonnin P Lefevre V Beaufils M Comparison of nifedipine and atenolol in treatment of moderate pregnancy hypertension. Proceedings of 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy, 1990:340"},{"key":"10.1002\/14651858.CD002252-BIB105|cit105","unstructured":"Yuen FT Mo YP Yin LC Terence L A double-blind randomised placebo controlled trial of labetalol in the treatment of mild pregnancy induced hypertension. Proceedings of 2nd International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1993; Hong Kong, Singapore, 1993"},{"key":"10.1002\/14651858.CD002252-BIB106|cit106","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000010080","article-title":"Calcium dobesilate lowers the blood pressure in mild to moderate midtrimester hypertension: a pilot study","volume":"47","author":"Tamas","year":"1999","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD002252-BIB107|cit107","unstructured":"Tamas P Csermely T Szabo EI Doxium - a novel drug in the management of gestational hypertension? 16th European Congress of Perinatal Medicine; 1998 June 10-13; Zagreb, 1998"},{"key":"10.1002\/14651858.CD002252-BIB108|cit108","first-page":"181","article-title":"Effects of doxium 500(tm) in gestational hypertension","volume":"60","author":"Tamas","year":"1997","journal-title":"Magyar Noorvosok Lapja"},{"key":"10.1002\/14651858.CD002252-BIB109|cit109","unstructured":"Davidson A Ellenbogen A Jaschevatzky O Attias Y Anderman S Grunstein S Randomized comparison of pindolol and atenolol for treatment of hypertension during pregnancy. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:99"},{"key":"10.1002\/14651858.CD002252-BIB110|cit110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jcu.1870200205","article-title":"Flow velocity analysis of umbilical and uterine artery flow in pre-eclampsia treated with propranolol or pindolol","volume":"20","author":"Meizner","year":"1992","journal-title":"Journal of Clinical Ultrasound"},{"key":"10.1002\/14651858.CD002252-BIB111|cit111","unstructured":"Martinelli P Ferrara LA Pasanisi F Arpaia F Paladini D Mancini M Nifedipine and atenolol in the treatment of pregnancy associated hypertension. 5th International Congress for the International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, England, 1986:128"},{"issue":"4","key":"10.1002\/14651858.CD002252-BIB112|cit112","first-page":"684","article-title":"Randomised comparison of calcium antagonists and beta-blockers in the treatment of pregnancy-induced hypertension","volume":"48","author":"Marlettini","year":"1990","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD002252-BIB113|cit113","unstructured":"Di Iorio R Horvath S Marinoni E Manzari G Martinico E Bresadola M Use of a thromboxane receptor inhibitor in pregnancy-induced hypertension. Proceedings of the 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy, 1990:75"},{"key":"10.1002\/14651858.CD002252-BIB114|cit114","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0020-7292(95)02351-C","article-title":"Labetalol vs methyldopa in the treatment of pregnancy-induced hypertension","volume":"49","author":"El-Qarmalawi","year":"1995","journal-title":"International Journal of Gynecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD002252-BIB115|cit115","first-page":"16","article-title":"The clinical and hemodynamic aspects of using peripheral vasodilators in hypertension in pregnant women","volume":"1993","author":"Osadchaia","year":"1993","journal-title":"Akusherstvo i Ginekologia"},{"key":"10.1002\/14651858.CD002252-BIB116|cit116","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1515\/jpme.1996.24.2.177","article-title":"Randomised controlled trial of methyldopa and isradipine in preeclampsia - effects on uteroplacental and fetal hemodynamics","volume":"24","author":"Montan","year":"1996","journal-title":"Journal of Perinatal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002252-BIB117|cit117","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1447-0756.1998.tb00080.x","article-title":"Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy","volume":"24","author":"Yin","year":"1998","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1002\/14651858.CD002252-BIB118|cit118","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1471-0528.1988.tb06818.x","article-title":"The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy","volume":"95","author":"Lindow","year":"1988","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB119|cit119","first-page":"458","article-title":"Indoramin in the treatment of pregnancy hypertension","volume":"78","author":"Anthony","year":"1990","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB120|cit120","first-page":"192","article-title":"The effect of nifedipine on fetal umbilical artery Doppler waveforms in pregnancies complicated by hypertension","volume":"79","author":"Puzey","year":"1991","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB121|cit121","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(97)06408-8","article-title":"Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia","volume":"350","author":"Steyn","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002252-BIB122|cit122","unstructured":"Torres Pons PJ Roca M Codina C Cobo E Cararach V Gonzalez-Merlo J Labetalol in the treatment of mild hypertension in pregnancy. A double blind controlled trial. 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Quebec, Canada, 1988:102"},{"key":"10.1002\/14651858.CD002252-BIB123|cit123","first-page":"87","article-title":"A comparison of nifedipine with methyldopa in pregnancy induced hypertension","volume":"39","author":"Jayawardana","year":"1994","journal-title":"Ceylon Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB125|cit124","unstructured":"Montan S Ingemarsson I Marsal K Sjoberg NO Negative influence of atenolol compared with pindolol on fetal hemodynamics in pregnancies with hypertension - a controlled study. Proceedings of 7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy, 1990:192"},{"key":"10.1002\/14651858.CD002252-BIB124|cit125","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/bmj.304.6832.946","article-title":"Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics","volume":"304","author":"Montan","year":"1992","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB126|cit126","unstructured":"Redman CWG A controlled trial of the treatment of hypertension in pregnancy: labetalol compared with methyldopa. The investigation of labetalol in the management of hypertension in pregnancy. International Congress Series 591. Amsterdam: Excerpta Medica, 1978:101-10"},{"key":"10.1002\/14651858.CD002252-BIB127|cit127","doi-asserted-by":"crossref","unstructured":"Redman CWG Controlled trials of treatment of hypertension during pregnancy. Proceedings of the 8th International Congress of Nephrology; 1981; Athens, Greece, 1981:523-4","DOI":"10.1097\/00006254-198208000-00007"},{"key":"10.1002\/14651858.CD002252-BIB128|cit128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.1991.tb10339.x","article-title":"Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol","volume":"98","author":"Harper","year":"1991","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB129|cit129","first-page":"557","article-title":"The effect of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies","volume":"57","author":"Welt","year":"1981","journal-title":"Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD002252-BIB130|cit130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7863\/jum.1991.10.6.301","article-title":"Effect of calcium channel blocker nifedipine on uterine artery flow velocity waveforms","volume":"10","author":"Thaler","year":"1991","journal-title":"Journal of Ultrasound in Medicine"},{"issue":"81","key":"10.1002\/14651858.CD002252-BIB131|cit131","first-page":"101","article-title":"Labetalol in the treatment of hypertension associated with pregnancy","volume":"24","author":"S\u00e1nchez","year":"1985","journal-title":"Centro m\u00e9dico"},{"key":"10.1002\/14651858.CD002252-BIB132|cit132","unstructured":"Lule J Aspirin and methyldopa for moderate hypertension in pregnancy Personal communication"},{"key":"10.1002\/14651858.CD002252-BIB133|cit133","unstructured":"Weiner CP Trial to evaluate oral hypotensive agents in early onset preeclampsia Personal communication"},{"key":"10.1002\/14651858.CD002252-BIB134|cit134","doi-asserted-by":"crossref","first-page":"700","DOI":"10.5694\/j.1326-5377.1993.tb121919.x","volume":"158","year":"1993","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD002252-BIB135|cit135","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1471-0528.1999.tb08442.x","article-title":"Lack of consistency in research papers over the definition of pre-eclampsia","volume":"106","author":"Chappell","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB136|cit136","first-page":"1245","article-title":"Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy","volume":"157","year":"1997","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD002252-BIB137|cit137","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.290.6461.17","article-title":"Overview of randomised trials of diuretics in pregnancy","volume":"290","author":"Collins","year":"1985","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD002252-BIB138|cit138","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0002-9378(88)90090-7","article-title":"The classification and definition of the hypertensive disorders of pregnancy","volume":"158","author":"Davey","year":"1988","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB139|cit139","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1471-0528.1992.tb13818.x","article-title":"Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean","volume":"99","author":"Duley","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD002252-BIB140|cit140","article-title":"Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy (Cochrane Review)","author":"Duley","year":"2000","journal-title":"The Cochrane Library"},{"issue":"2","key":"10.1002\/14651858.CD002252-BIB141|cit141","article-title":"Drugs for rapid treatment of very high blood pressure during pregnancy (Cochrane Review)","author":"Duley","year":"2000","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD002252-BIB142|cit142","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0002-8703(79)90195-9","article-title":"Clinical pharmacology of the new beta-adrenergic drugs. Part 1. Pharmacodynamic and pharmacokinetic properties","volume":"97","author":"Frishman","year":"1979","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD002252-BIB143|cit143","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/0002-9378(90)90653-O","article-title":"National high blood pressure education program working group report on high blood pressure in pregnancy","volume":"163","author":"Gifford","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB144|cit144","volume-title":"Report on confidential enquiries into maternal death in the United Kingdom 1994-1996. Department of Health Welsh Office, Scottish Office Home and Health Department, Department of Health and Social Security Northern Ireland","author":"HMSO","year":"1998"},{"issue":"2","key":"10.1002\/14651858.CD002252-BIB145|cit145","article-title":"Abdominal decompression for suspected fetal compromise\/pre-eclampsia (Cochrane Review)","author":"Hofmeyr","year":"2000","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD002252-BIB146|cit146","article-title":"The Growth Restriction Intervention Trial (GRIT): interim progress report","author":"Hornbuckle","year":"1999"},{"key":"10.1002\/14651858.CD002252-BIB147|cit147","volume-title":"Clinical physiology in obstetrics","author":"Hytten","year":"1980"},{"key":"10.1002\/14651858.CD002252-BIB148|cit148","first-page":"593","article-title":"A centrally mediated peripheral hypotensive effect of methyldopa","volume":"175","author":"Ingenito","year":"1970","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD002252-BIB149|cit149","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/00005344-198000021-00002","article-title":"Clonidine in the central nervous system: site of mechanism of hypotensive action","volume":"2","author":"Isaac","year":"1980","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD002252-BIB150|cit150","article-title":"Antiplatelet agents for preventing and treating pre-eclampsia (Cochrane Review)","author":"Knight","year":"2000","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD002252-BIB151|cit151","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM198509123131107","article-title":"Hypertension in pregnancy","volume":"313","author":"Lindheimer","year":"1985","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002252-BIB152|cit152","article-title":"Oral beta-blockers for mild to moderate hypertension during pregnancy","author":"Magee","year":"2000","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD002252-BIB153|cit153","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1471-0528.1999.tb08396.x","article-title":"Evaluation of the definition of pre-eclampsia","volume":"106","author":"North","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD002252-BIB154|cit154","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(88)91667-4","article-title":"Revised definition of pre-eclampsia","volume":"1","author":"Redman","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002252-BIB155|cit155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/0140-6736(93)90890-S","article-title":"Management of pre-eclampsia","volume":"341","author":"Redman","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002252-BIB156|cit156","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/0140-6736(93)90889-O","article-title":"Pre-eclampsia: more than pregnancy-induced hypertension","volume":"341","author":"Roberts","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002252-BIB157|cit157","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2125.1980.tb01784.x","article-title":"Effects of nifedipine on resistance vessels, arteries and veins in man","volume":"10","author":"Robinson","year":"1980","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD002252-BIB158|cit158","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1172\/JCI102972","article-title":"Studies on hydralazine; evidences for a peripheral site of action","volume":"33","author":"Stunkard","year":"1954","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD002252-BIB159|cit159","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0002-9378(89)90777-1","article-title":"The measuring of blood pressure during pregnancy","volume":"161","author":"Villar","year":"1989","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD002252-BIB160|cit160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)08049-0","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis","volume":"355","author":"Dadelszen","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002252-BIB161|cit161","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9378(88)90782-X","article-title":"Geographic variation in the incidence of hypertension in pregnancy","volume":"158","year":"1988","journal-title":"American Journal of Obstetrics and Gynecology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD002252\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T10:02:01Z","timestamp":1682589721000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002252"}},"subtitle":[],"editor":[{"given":"Edgardo","family":"Abalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2001,4,23]]},"references-count":161,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002252","relation":{},"subject":[],"published":{"date-parts":[[2001,4,23]]}}}